Director/PDMR Shareholding

Summary by AI BETAClose X

On 05/11/2026 the Trustees of the Judges Scientific Share Incentive Plan purchased a total of 24 ordinary shares at 3,400.0p each (£34.00) on the London Stock Exchange AIM; purchases comprised 4 shares each for Tim Prestidge (CEO), Bradley Ormsby (CFO) and Ian Wilcock (Group Commercial Director) and 6 shares each for Rik Armitage (Group Acquisition Executive) and John Dunne (Portfolio Chief Executive).

Disclaimer*

UK 100

Latest directors dealings